A comparative network analysis of high-risk MYCN amplified and high-risk MYCN non-amplified neuroblastoma patients
Erin Chang, Charissa J. Chou, Wen-I Chang, Joshua N. Honeyman, Alper Uzun
This study compares PPI networks between high-risk MYCN amplified and non-amplified neuroblastoma patients to identify predictive biomarkers.
bioRxiv · Oct 24, 2024 · PreprintBioinformatics